Literature DB >> 11861242

Bronchodilator therapy and hyperactivity in preschool children.

I Hadjikoumi1, P Loader, M Bracken, A D Milner.   

Abstract

The common report of parents of asthmatic children that inhaled/nebulised salbutamol causes overactive behaviour was investigated. Nineteen children were assessed in a standardised setting before and after the administration of nebulised salbutamol and placebo. Neither parental report nor observer ratings suggested any significant increase in the child's level of activity.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11861242      PMCID： PMC1719100          DOI： 10.1136/adc.86.3.202

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  3 in total

Review 1.  Review of side effects associated with beta agonists.

Authors:  D L Spangler
Journal:  Ann Allergy       Date:  1989-01

2.  The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity.

Authors:  C K Conners; G Sitarenios; J D Parker; J N Epstein
Journal:  J Abnorm Child Psychol       Date:  1998-08

Review 3.  Adverse reactions to beta 2-agonist bronchodilators.

Authors:  K M Lulich; R G Goldie; G Ryan; J W Paterson
Journal:  Med Toxicol       Date:  1986 Jul-Aug
  3 in total
  2 in total

1.  Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands.

Authors:  T W de Vries; J J de Langen-Wouterse; E van Puijenbroek; E J Duiverman; L T W de Jong-Van den Berg
Journal:  Eur J Clin Pharmacol       Date:  2006-04-01       Impact factor: 2.953

2.  Early wheezing phenotypes and cognitive development of 3-yr-olds. Community-recruited birth cohort study.

Authors:  Wieslaw Jedrychowski; Frederica P Perera; Jeffery Jankowski; Umberto Maugeri; Dorota Mrozek-Budzyn; Elzbieta Mroz; Elzbieta Flak; Anita Skarupa; Susan Edwards; Ilona Lisowska-Miszczyk
Journal:  Pediatr Allergy Immunol       Date:  2009-06-22       Impact factor: 6.377
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.